Craig C. Hopkinson, the EVP R&D of $ALKS, sold 33,108 shares of the company on 02-12-2025 for an estimated $1,101,470. We received data on the trade from a recent SEC filing. This was a sale of approximately 36.4% of their shares of this class of stock. Following this trade, they now own 57,875 shares of this class of $ALKS stock.
$ALKS Insider Trading Activity
$ALKS insiders have traded $ALKS stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $ALKS stock by insiders over the last 6 months:
- CRAIG C. HOPKINSON (EVP R&D, Chief Medical Officer) has made 0 purchases and 10 sales selling 604,446 shares for an estimated $19,860,519.
- CHRISTIAN TODD NICHOLS (SVP, Chief Commercial Officer) sold 5,208 shares for an estimated $151,813
- CATO T LAURENCIN sold 2,691 shares for an estimated $85,708
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ALKS Hedge Fund Activity
We have seen 169 institutional investors add shares of $ALKS stock to their portfolio, and 189 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 5,645,762 shares (-44.6%) from their portfolio in Q4 2024, for an estimated $162,372,115
- DEEP TRACK CAPITAL, LP removed 3,500,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $100,660,000
- AVORO CAPITAL ADVISORS LLC added 2,450,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $70,462,000
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,986,294 shares (+18.0%) to their portfolio in Q3 2024, for an estimated $55,596,369
- COMMODORE CAPITAL LP added 1,525,000 shares (+110.9%) to their portfolio in Q3 2024, for an estimated $42,684,750
- ARMISTICE CAPITAL, LLC removed 1,448,654 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $41,663,289
- WESTFIELD CAPITAL MANAGEMENT CO LP removed 1,316,605 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $36,851,773
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
